Conflict of interest statement: MFE, YM, TV, JK, JS, CF, EM, CL, and DM are 
current or former employees of, and own/owned stock in, MSD. JLC has received 
in-kind research support from Avid Radiopharmaceuticals and Teva Pharmaceuticals 
and has served as a consultant to the following companies: Acadia, Accera, 
Actinogen, ADAMAS, Alkahest, Allergan, Alzheon, Avanir, BiOasis Technologies, 
Biogen, Boehinger-Ingelheim, Bracket, Casava, Eisai, GE Healthcare, Genentech, 
Grifols, Kyowa, Lundbeck, Medavante, MSD, Nutricia, Orion, Otsuka, Pfizer, QR 
Pharma, Resverlogix, Roche, Samus, Samumed, Suven, Takeda, Toyoma, United 
Neuroscience. He owns stock in ADAMAS, Prana, Sonexa, MedAvante, Neurotrax, and 
Neurokos. He is the copyright holder on the Neuropsychiatric Inventory. He 
receives support from Keep Memory Alive and COBRE award P20GM109025. PNT has 
received consulting fees from Acadia, Abbott Laboratories, AbbVie, AC Immune, 
Auspex, Boehringer-Ingelheim, Chase Pharmaceuticals, Eisai, GliaCure, Insys 
Therapeutics, and Pfizer. He has received consulting fees and research support 
from AstraZeneca, Avanir, Eli Lilly, Lundbeck, MSD, Roche, and research support 
only Amgen, Avid, Biogen, Elan, Functional Neuromodulation (f (nm)), GE 
Healthcare, Genentech, Novartis, and Targacept. He has received other research 
support from the NIA and Arizona Department of Health Services and holds stock 
options in ADAMAS. PSA has served as a consultant to the following companies: 
NeuroPhage, Eli Lilly, MSD, Avanir, Roche, Novartis, Pfizer, AstraZeneca, 
Janssen, Lundbeck, Biogen, Probiodrug, Anavex, Abbvie, Janssen, Cytox, and aTyr. 
He receives research support from Eli Lilly, Janssen, the Alzheimer’s 
Association, and the NIH. BV has served as a consultant to the following 
companies: Transition Therapeutics, Takeda, Otsuka, Lilly, Nestlé, MSD, Biogen, 
and Roche. He receives research support from Abbvie, Lilly, MSD, Otsuka, Sanofi, 
Alzheon, Astra-Zénéca, LPG Systems Nestlé, The Alzheimer’s Association, The 
Alzheimer Drug Discovery Foundation, The European Commission, and French 
Ministry of Health.